Ascentage Pharma Group International (AAPG) Competitors $42.04 -0.81 (-1.89%) As of 07/7/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock AAPG vs. ITCI, GMAB, RDY, VTRS, QGEN, MRNA, ASND, BBIO, BPMC, and VRNAShould you be buying Ascentage Pharma Group International stock or one of its competitors? The main competitors of Ascentage Pharma Group International include Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Viatris (VTRS), Qiagen (QGEN), Moderna (MRNA), Ascendis Pharma A/S (ASND), BridgeBio Pharma (BBIO), Blueprint Medicines (BPMC), and Verona Pharma PLC American Depositary Share (VRNA). These companies are all part of the "pharmaceutical products" industry. Ascentage Pharma Group International vs. Its Competitors Intra-Cellular Therapies Genmab A/S Dr. Reddy's Laboratories Viatris Qiagen Moderna Ascendis Pharma A/S BridgeBio Pharma Blueprint Medicines Verona Pharma PLC American Depositary Share Ascentage Pharma Group International (NASDAQ:AAPG) and Intra-Cellular Therapies (NASDAQ:ITCI) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, earnings, dividends, profitability, analyst recommendations, valuation and risk. Do analysts recommend AAPG or ITCI? Intra-Cellular Therapies has a consensus target price of $109.70, indicating a potential downside of 16.81%. Given Intra-Cellular Therapies' higher probable upside, analysts clearly believe Intra-Cellular Therapies is more favorable than Ascentage Pharma Group International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ascentage Pharma Group International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Intra-Cellular Therapies 0 Sell rating(s) 10 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Is AAPG or ITCI more profitable? Ascentage Pharma Group International has a net margin of 0.00% compared to Intra-Cellular Therapies' net margin of -14.07%. Ascentage Pharma Group International's return on equity of 0.00% beat Intra-Cellular Therapies' return on equity.Company Net Margins Return on Equity Return on Assets Ascentage Pharma Group InternationalN/A N/A N/A Intra-Cellular Therapies -14.07%-9.93%-8.38% Which has stronger valuation and earnings, AAPG or ITCI? Ascentage Pharma Group International has higher earnings, but lower revenue than Intra-Cellular Therapies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAscentage Pharma Group International$134.35M27.26-$55.54MN/AN/AIntra-Cellular Therapies$680.50M20.64-$139.67M-$0.73-180.64 Does the media prefer AAPG or ITCI? In the previous week, Ascentage Pharma Group International had 1 more articles in the media than Intra-Cellular Therapies. MarketBeat recorded 2 mentions for Ascentage Pharma Group International and 1 mentions for Intra-Cellular Therapies. Ascentage Pharma Group International's average media sentiment score of 0.00 equaled Intra-Cellular Therapies'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ascentage Pharma Group International 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Intra-Cellular Therapies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders have more ownership in AAPG or ITCI? 92.3% of Intra-Cellular Therapies shares are held by institutional investors. 2.6% of Intra-Cellular Therapies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryAscentage Pharma Group International beats Intra-Cellular Therapies on 7 of the 12 factors compared between the two stocks. Get Ascentage Pharma Group International News Delivered to You Automatically Sign up to receive the latest news and ratings for AAPG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AAPG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AAPG vs. The Competition Export to ExcelMetricAscentage Pharma Group InternationalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.73B$2.91B$5.52B$9.02BDividend YieldN/A2.44%5.24%4.08%P/E RatioN/A20.3027.1920.04Price / Sales27.26250.25413.81108.84Price / CashN/A41.7026.2128.59Price / Book87.587.397.925.55Net Income-$55.54M-$55.04M$3.17B$248.49M7 Day Performance7.82%2.51%1.78%4.87%1 Month Performance48.13%-0.21%1.26%6.63%1 Year PerformanceN/A3.41%33.30%20.38% Ascentage Pharma Group International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AAPGAscentage Pharma Group InternationalN/A$42.04-1.9%N/AN/A$3.73B$134.35M0.00600ITCIIntra-Cellular Therapies0.9246 of 5 stars$131.87flat$109.70-16.8%N/A$14.05B$680.50M-151.57560News CoverageGMABGenmab A/S3.8379 of 5 stars$20.50-1.1%$37.60+83.4%-19.7%$13.29B$3.12B11.652,682RDYDr. Reddy's Laboratories2.6782 of 5 stars$15.06-1.8%$16.95+12.5%-3.4%$12.80B$3.81B22.8227,811VTRSViatris2.6519 of 5 stars$9.01-1.2%$10.40+15.4%-10.9%$10.70B$14.74B-2.8432,000QGENQiagen3.8533 of 5 stars$47.76-0.6%$49.40+3.4%+18.8%$10.68B$1.98B119.765,765Dividend AnnouncementMRNAModerna4.3593 of 5 stars$27.16-1.4%$46.61+71.6%-74.7%$10.65B$3.24B-3.115,800Gap UpASNDAscendis Pharma A/S3.5704 of 5 stars$172.22-0.4%$220.67+28.1%+29.6%$10.57B$393.54M-27.421,017BBIOBridgeBio Pharma4.6716 of 5 stars$44.86-0.6%$57.42+28.0%+68.9%$8.57B$221.90M-12.71400High Trading VolumeBPMCBlueprint Medicines1.3544 of 5 stars$128.110.0%$128.060.0%+15.0%$8.28B$508.82M-51.87640High Trading VolumeVRNAVerona Pharma PLC American Depositary Share2.7644 of 5 stars$93.82-0.6%$101.10+7.8%+466.1%$8.04B$42.28M-46.9130Positive News Related Companies and Tools Related Companies ITCI Alternatives GMAB Alternatives RDY Alternatives VTRS Alternatives QGEN Alternatives MRNA Alternatives ASND Alternatives BBIO Alternatives BPMC Alternatives VRNA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AAPG) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ascentage Pharma Group International - Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Ascentage Pharma Group International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AAPG Stock Alerts